Blood plasma and bone marrow interstitial fluid metabolomics of sickle cell disease patients with osteonecrosis: An exploratory study to dissect biochemical alterations
- 28 November 2022
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 539, 18-25
Abstract
No abstract availableKeywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado da Bahia
This publication has 28 references indexed in Scilit:
- OsteonecrosisOrthopaedics and Trauma, 2018
- Classification systems of hip osteonecrosis: an updated reviewInternational Orthopaedics, 2018
- Osteonecrosis in sickle cell disease patients from Bahia, Brazil: a cross-sectional studyInternational Orthopaedics, 2018
- Lipid profiles in French West Indies sickle cell disease cohorts, and their general populationLipids in Health and Disease, 2018
- Orthopaedic Manifestations of Sickle Cell DiseaseJournal of the American Academy of Orthopaedic Surgeons, 2018
- Serum metabolomic study for detecting biomarkers of non-traumatic osteonecrosis of the femoral headMetabolomics, 2017
- Metabolomic study of the bone trabecula of osteonecrosis femoral head patients based on UPLC–MS/MSMetabolomics, 2016
- Unique plasma metabolomic signature of osteonecrosis of the femoral headJournal of Orthopaedic Research, 2015
- Lactate Dehydrogenase and Severity of Pain in Children with Sickle Cell DiseaseActa Haematologica, 2011
- Metabolomic Data Processing, Analysis, and Interpretation Using MetaboAnalystCurrent Protocols in Bioinformatics, 2011